U.S. Supreme Court rejects Allergan bid to shield drug patents from review
The U.S. Supreme Court on Monday cast aside pharmaceutical company Allergan Plc's unorthodox bid to shield patents from a federal administrative court's review by transferring them to a Native American tribe.
from Reuters: Health News https://reut.rs/2Z9liPH
http://bit.ly/2zwRqiM